Literature DB >> 9020179

High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein.

D A Nelson1, N A Krucher, J W Ludlow.   

Abstract

pRb controls cell proliferation by restricting inappropriate entry of cells into the cell division cycle. As dephosphorylation of pRb during mitotic exit activates its growth suppressive function, identification of the protein phosphatase that dephosphorylates pRb, and characterization of the mechanism of its regulation, are essential to elucidating the mechanisms of cell growth control. By fractionating mitotic CV-1P cell extracts, we identify the protein phosphatase which dephosphorylates pRb as a type 1 serine/threonine phosphoprotein phosphatase (PP1). Molecular sizing analyses indicate that the catalytic enzyme (PP1c) is present in a high molecular weight complex, with a predicted molecular mass of 166 kDa. PP1-interacting proteins in the mitotic cell extracts are identified. Two PP1-interacting proteins (41 and 110 kDa) are shown to form distinct complexes with PP1c from fractions of separated mitotic cell extracts containing phosphorylase phosphatase activity. However, only the 110-kDa PP1-interacting protein is present in fractions containing pRb-directed phosphatase activity, identifying this protein as a putative activator of PP1 function toward pRb during mitosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020179     DOI: 10.1074/jbc.272.7.4528

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells.

Authors:  Gabriel De Leon; Margaret Cavino; Mikilyn D'Angelo; Nancy A Krucher
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

2.  Localization of myosin phosphatase target subunit and its mutants.

Authors:  Yue Wu; Andrea Murányi; Ferenc Erdodi; David J Hartshorne
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

3.  Inactivation of Cdk1/Cyclin B in metaphase-arrested mouse FT210 cells induces exit from mitosis without chromosome segregation or cytokinesis and allows passage through another cell cycle.

Authors:  James R Paulson
Journal:  Chromosoma       Date:  2007-01-26       Impact factor: 4.316

Review 4.  Mechanisms controlling cell cycle exit upon terminal differentiation.

Authors:  Laura A Buttitta; Bruce A Edgar
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

5.  MicroRNAs as molecular classifiers for cancer.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

6.  Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7.

Authors:  J M Sterner; S Dew-Knight; C Musahl; S Kornbluth; J M Horowitz
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 7.  PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates.

Authors:  Alison Kurimchak; Xavier Graña
Journal:  Gene       Date:  2012-02-22       Impact factor: 3.688

8.  Dephosphorylation of threonine-821 of the retinoblastoma tumor suppressor protein (Rb) is required for apoptosis induced by UV and Cdk inhibition.

Authors:  Brandon Lentine; Lisa Antonucci; Ray Hunce; Justina Edwards; Valerie Marallano; Nancy A Krucher
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

9.  RB activation defect in tumor cell lines.

Authors:  Cristina Broceño; Scott Wilkie; Sibylle Mittnacht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

10.  An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.

Authors:  Alexander Hirschi; Matthew Cecchini; Rachel C Steinhardt; Michael R Schamber; Frederick A Dick; Seth M Rubin
Journal:  Nat Struct Mol Biol       Date:  2010-08-08       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.